-
Characterization of Chronic Renal Allograft Dysfunction at Single Cell Resolution
-
Characterization of Kidney Small Extracellular Vesicles Released During Normothermic Machine Perfusion
-
Characterization of Retransplantation Following Graft Failure Due to Bkvn
-
Characterization of SGLT2 Inhibitor Use After Abdominal Transplant
-
Characterizing Kidney Transplant Recipients with SARS-CoV-2: An Academic Single Center Experience
-
Characterizing the Early Impact of the Kidney Accelerated Placement Project on Hard-to-place Kidneys
-
CHBP Induces Stronger Immunosuppressive CD127+ M-MDSC via Erythropoietin Receptor
-
Classification of Distinct Patterns of Ischemic Cholangiopathy Following DCD Liver Transplantation: Distinct Clinical Courses and Long-Term Outcomes from a Multicenter Cohort
-
Clazakizumab (clz, Anti-il-6 Antibody) Treatment Affects Il-6/il-6r Signaling by Increasing Soluble Gp130 (sgp130) in Hla-sensitized Kidney Transplant Patients (hs Ktx Pts) Treated for Chronic Antibody-mediated Rejection (cabmr)
-
Clazakizumab for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: Phase 3 IMAGINE Study Design
- « Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- …
- 139
- Next Page »